USBiological
Biosimilar
New
Reset all filters

Min CHF:
Max CHF:
  1-30 of 1019
Supplier Product name Cat.no. Pack size Price
Anti- CD11a, Efalizumab Biosimilar 045881-1MG 787,00
Anti- Evolocumab Biosimilar (PCSK9) 045880-1MG 787,00
Anti- 158P1D7 (Agensys patent 158P1D7) 048338-100uG 706,00
Anti- ACVRL1/ALK-1 (ascrinvacumab) 047982-100uG 706,00
Anti- Amyloid Beta (ponezumab) 047981-100uG 706,00
Anti- ANGPT2 (MEDI3617) 048031-100uG 706,00
Anti- ANGPTL8 (Regeneron patent ANGPTL8) 048358-100uG 706,00
Anti- B7-H2/ICOSL/CD275 (prezalumab) 047627-100uG 706,00
Anti- CALCA/CGRP (fremanezumab) 048304-100uG 706,00
Anti- CALCRL/CGRPR (erenumab) 047629-100uG 706,00
Anti- CCL5/RANTES (NI-0701) 047873-100uG 706,00
Anti- CD20 (Regeneron patent CD20) 048375-100uG 706,00
Anti- CD200 (samalizumab) 048291-100uG 706,00
Anti- CD28 (FR104) 048082-100uG 706,00
Anti- CD3 (visilizumab) 047888-100uG 706,00
Anti- CD7 (grisnilimAb) 048138-100uG 706,00
Anti- CD83 (Genentech patent CD83) 048391-100uG 706,00
Anti- CDH11/Cadherin-11 (RG6125) 047928-100uG 706,00
Anti- CEACAM6/CD66c (tinurilimab) 047711-100uG 706,00
Anti- Clusterin (AB-16B5) 048408-100uG 706,00
Anti- Complement C5 (lendalizumab) 048410-100uG 706,00
Anti- Complement C5 (ravulizumab) 047695-100uG 706,00
Anti- CX3CL1/Fractalkine (quetmolimab) 048437-100uG 706,00
Anti- CXADR (Med. Bio. Labs patent CXADR) 048438-100uG 706,00
Anti- CXCL8/IL-8 (ABX-IL8) 048266-100uG 706,00
Anti- DLL4 (demcizumab) 048497-100uG 706,00
Anti- DLL4 (navicixizumab) 047656-100uG 706,00
Anti- DPP4/CD26 (begelomab) 048283-100uG 706,00
Anti- EPOR (Abbott patent EPO Receptor) 048461-100uG 706,00
Anti- ERBB1/EGFR/HER1 (panitumumab) 047655-100uG 706,00
  1-30 of 1019

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00

Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

© Copyright 2021 Lucerna-Chem AG, Switzerland

Order Conditions | Privacy Policy | Terms & Conditions | Impressum